Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation
Molecular Medicine Reports · 2025
DOI: 10.3892/mmr.2025.13692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Jiajie Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China. Hauptthemen laut MEDLINE: Pyroptosis, Curcumin, Colorectal Neoplasms, Caspase 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a substantial global health challenge, with current treatments often leading to relapse and metastasis. Curcumin, a natural compound derived from turmeric, has shown promise in cancer therapy; however, its mechanisms in CRC are not fully understood. The present study aimed to investigate the role of curcumin in inducing pyroptosis, a form of inflammatory cell death, through caspase‑1 activation in CRC cells. Human CRC cell lines (HCT‑116 and SW480) and normal colon epithelial cells (FHC) were treated with curcumin at varying concentrations. Cell viability, migration and invasion were assessed using Cell Counting Kit‑8, wound healing and Transwell assays, respectively. Pyroptosis was evaluated through lactate dehydrogenase (LDH) release, TUNEL staining and western blot analysis of pyroptosis‑related proteins (caspase‑1, gasdermin D, nucleotide‑binding oligomerization domain‑like receptor protein 3, IL‑1β and IL‑18). The role of caspase‑1 was further examined using the inhibitor VX‑765. Curcumin significantly reduced CRC cell viability, migration and invasion in a dose‑dependent manner. In addition, it induced pyroptosis, as evidenced by cell membrane swelling, increased LDH release and upregulation of pyroptosis‑related proteins. Inhibition of caspase‑1 with VX‑765 attenuated these effects, confirming the role of caspase‑1 in curcumin‑induced pyroptosis. In conclusion, curcumin may exert anti‑CRC effects by inducing caspase‑1‑mediated pyroptosis, highlighting its potential as a therapeutic agent. These findings suggest that curcumin could be integrated into current CRC treatment strategies, particularly in targeting pyroptosis to enhance tumor suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China.
- Department of Oncology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China.
- Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
- School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
Zitieren
APA
Zhu, J., Yang, L., Fang, Z., Chen, J., Wu, Y., Liu, H., Liu, S., & Fei, B. (2025). Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13692
Vancouver
Zhu J, Yang L, Fang Z, Chen J, Wu Y, Liu H, et al. Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation. Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13692
BibTeX
@article{Zhu2025,
author = {Zhu, Jiajie and Yang, Liangjun and Fang, Zheng and Chen, Jiabin and Wu, Yeqian and Liu, Haiyan and Liu, Shan and Fei, Baoying},
title = {Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation},
journal = {Molecular Medicine Reports},
year = {2025},
doi = {10.3892/mmr.2025.13692}
}
EUVIMED